Esprit To Market Estrogen Therapy Estrasorb In 2006
This article was originally published in The Pink Sheet Daily
Executive Summary
The company gains rights to Novavax' topical estrogen therapy Estrasorb after the failure of Novavax' copromotion deal with King.